Beta blockers: City docs advise against sudden regime change | Kolkata News – Times of India

Kolkata: The City cardiologists Patients have been advised to stop the drug after an observational study on the use of beta blockers for the management of heart attacks claimed that the benefits of these drugs may not be as significant as their widespread use.
Cardiologists on Wednesday addressed anxious calls from patients who wanted to know whether they should continue taking the drug and advised those who are on this drug regimen to take pills. “In case of any doubt, consult the doctors. Abruptly discontinuing the medicine can have adverse effects,” said a cardiologist.
Beta blockers are a group of drugs used to treat angina, irregular heart rhythms, high blood pressure associated with pregnancy, high blood pressure with coronary artery disease, and for patients who have already had a heart attack or who have had a heart attack. There is a high risk of having a stroke. heart attack.
“Beta blockers are the number one drug to prevent heart attack, heart failure, angina and pregnancy-induced hypertension. The new generation oral drugs are also very effective in preventing sudden cardiac deaths,” said PK Hajra, cardiologist, AMRI Dhakuria. are effective.
The observational study, conducted between 2005 and 2016, included more than 40,000 patients who had suffered a stroke and required hospital care. The researchers found no significant difference in risk between patients taking beta blockers and those not taking the drugs.
Doctors said that the study was done years ago and since then new medicines have come out. Cardiologists said more detailed studies and stronger evidence were needed.
“The evidence still exists that beta blockers are beneficial in patients who have already had a heart attack,” said Sunip Banerjee, a cardiologist at the Kolkata Heart and Lung Center.
Saroj Mondal, professor of cardiology at IPGMER, said that while beta blockers are not the first choice of drugs for the treatment of hypertension, it is effective in patients with low ejection fraction. “The IV beta blocker used in patients with myocardial infarction is now discouraged because of its potential side effects. But new-age oral beta blockers are effective in preventing sudden cardiac death from sudden pump failure in patients with ejection fraction,” Mondal said.
According to doctors, beta blocker is used as a fourth agent only when other medicines fail to control high blood pressure. “If a patient has high blood pressure, which is not controlled by the other three agents for a long time, or the patient also has a condition like coronary heart disease, then a beta blocker is recommended as an additional drug. Suvaro Banerjee, cardiologist, Apollo Multispeciality Hospital, said patients who are taking regular beta blockers should not take it without consulting their doctor.